Ce produit n'est pas destiné à diagnostiquer, traiter, guérir ou prévenir toute maladie. Ces déclarations n'ont pas été évaluées par la Food and Drug Administration.
Ces informations sont fournies à titre éducatif uniquement et ne remplacent pas un avis médical professionnel, un diagnostic ou un traitement. Consultez toujours votre professionnel de santé avant d'utiliser des plantes, surtout si vous êtes enceinte, allaitez, prenez des médicaments ou avez une condition médicale.
Juncus effusus contains bioactive compounds including luteolin, phenolics, sterols, and fatty acids that contribute to its medicinal effects. Luteolin, a flavonoid, exhibits anti-inflammatory and antioxidant properties that may help clear heat and reduce oxidative stress. The herb's diuretic action is attributed to its effects on kidney function, promoting urine output. In Traditional Chinese Medicine theory, Juncus effusus enters the heart and small intestine channels, helping to clear heart fire and calm the mind. Evidence level: C (preliminary research and traditional use).
Does Juncus effusus interact with any medications?
There is limited clinical research on drug interactions with Juncus effusus. Due to its diuretic properties, it may potentially interact with diuretic medications such as furosemide or hydrochlorothiazide, potentially enhancing their effects and increasing the risk of dehydration or electrolyte imbalances. Caution is advised when combining with other herbs or medications that affect fluid balance or kidney function. Always consult a qualified healthcare provider before combining Juncus effusus with prescription medications. Evidence level: C (theoretical interactions based on mechanism).
What is the recommended dosage for Juncus effusus?
The typical adult dosage for Juncus effusus dried pith is 1-3 grams daily, prepared as a decoction. In Traditional Chinese Medicine and Japanese Kampo practice, the herb is commonly boiled in water to extract its active compounds. Dosage may vary based on individual constitution, the specific condition being treated, and whether it is used alone or in combination with other herbs. Always follow the guidance of a qualified practitioner familiar with TCM or Kampo medicine. Evidence level: Traditional use.
Is Juncus effusus safe to take during pregnancy?
Juncus effusus is considered unsafe during pregnancy and should be avoided. In Traditional Chinese Medicine, this herb has properties that may affect pregnancy, and insufficient safety data exists for pregnant women. The diuretic effects could potentially alter fluid balance during pregnancy, which may pose risks. Women who are pregnant, planning to become pregnant, or breastfeeding should not use Juncus effusus without explicit guidance from a qualified healthcare provider. Evidence level: C (traditional contraindication).
What is Juncus effusus used for in Traditional Chinese Medicine?
In Traditional Chinese Medicine, Juncus effusus (known as Deng Xin Cao) is primarily used to clear heat, promote urination, and calm the mind. It is commonly prescribed for conditions associated with heart fire, which may manifest as irritability, insomnia, restlessness, or mouth ulcers. The herb is also used to address urinary difficulties and promote fluid metabolism. Japanese Kampo medicine uses it similarly for conditions involving heat and urinary concerns. Evidence level: C (traditional use with limited clinical trials).
What are the side effects of Juncus effusus?
Juncus effusus is generally well tolerated when used appropriately at recommended doses. Few adverse effects have been reported in traditional use. However, due to its diuretic action, excessive use may lead to increased urination, potential dehydration, or electrolyte imbalances. In Traditional Chinese Medicine, it is contraindicated for individuals with deficiency cold patterns, as its cooling properties may worsen such conditions. Discontinue use if any unusual symptoms occur. Evidence level: C (traditional use data).
Fiche d'information compilée à partir de PubMed
Cette fiche a été compilée à partir de résumés PubMed (NIH) avec l'assistance d'une IA. Chaque affirmation factuelle est citée par un article PubMed réel (voir la liste des sources). Elle n'a pas encore été révisée par un humain — confirmez auprès d'un professionnel de santé avant utilisation.
Compilé à partir de 30 articles PubMed · modèle : gemma4:31b
Résumé
Juncus effusus is a cosmopolitan wetland plant used in Traditional Chinese Medicine for gynecological and urinary disorders [PMID:34498976, PMID:30892891]. Recent research suggests potential cognitive-enhancing and hepatoprotective properties [PMID:40068564, PMID:38325836].
Contexte
Juncus effusus, also known as softrush or common rush, is a perennial herbaceous helophytic plant in the Juncaceae family distributed globally in temperate damp or wet habitats [PMID:31195970, PMID:34027070].
Usages traditionnels
In Traditional Chinese Medicine (TCM), it has been used to treat gynecological disorders (relieving insomnia, preventing tinnitus, and reducing edema via diuretic effects), dysuria, and to promote diuresis for strangury and clear 'heart fire' [PMID:34498976, PMID:30892891, PMID:37312583]. It has also been used as an indigenous diuretic, antipyretic, and analgesic [PMID:35028318].
Composés actifs
The plant contains phenanthrenes and dihydrophenanthrenes (including effusol, dehydroeffusol, juncusol, and effususins A-D), cycloartane glucosides (juncosides I-V), phenolic compounds, glycerides, and flavonoids [PMID:34498976, PMID:22017742, PMID:7765629, PMID:26072042, PMID:37312583].
Mécanisme d'action
Hepatoprotective effects are mediated by suppressing serum ALT, AST, hepatic MDA, and TNF-α, while increasing superoxide dismutase (SOD) and promoting expression of Nrf2, NQO-1, HO-1, and GCLC [PMID:38325836]. Effusol may ameliorate ischemic stroke by targeting the NLRP3 protein to regulate NLRP3 inflammasome-mediated pyroptosis [PMID:39615210]. Dehydroeffusol has been shown to prevent amyloid-β-induced memory deficits [PMID:32333241].
Preuves cliniques
Preuve BCognitive and dexterous performance in elderly
A randomized, double-blind, placebo-controlled study of 41 participants found that J. effusus extract powder enriched with dehydroeffusol significantly improved scores in clue recall, clock-drawing, and assembly tasks over 24 weeks [PMID:40068564]
Preuve DRelaxation/Psychological state
Inhalation of volatile organic compounds from dried J. effusus increased alpha amplitudes of electroencephalogram and parasympathetic nervous activity, suggesting a relaxing effect despite a perceived sour/pungent scent [PMID:35162880]
Interactions médicamenteuses
Phenanthrenoids from J. effusus have been identified as inhibitors of organic anion transporters OAT1 and OAT3, which are involved in the renal elimination of various substrate molecules [PMID:30892891].
Synthèse des preuves
Evidence is primarily based on in vitro studies, animal models (mice), and one small-scale randomized controlled trial (n=41) for cognitive function. Most pharmacological claims are currently at the preclinical stage.
Sources PubMed
1.PMID: 38325836 (2024) — Protective Mechanisms of Juncus effusus and Carbonized Juncus effusus against D-Galactosamine-Induced Acute Liver Injury in Mice. · Chemical & pharmaceutical bulletin
2.PMID: 31176131 (2019) — Exposure of Juncus effusus to seven perfluoroalkyl acids: Uptake, accumulation and phytotoxicity. · Chemosphere
3.PMID: 34126808 (2022) — Phytoremediation of azoxystrobin and imidacloprid by wetland plant species Juncus effusus, Pontederia cordata and Sagittaria latifolia. · International journal of phytoremediation
4.PMID: 34498976 (2022) — Estrogenic and anti-neutrophilic inflammatory phenanthrenes from Juncus effusus L. · Natural product research
5.PMID: 30892891 (2019) — Dihydrophenanthrenes from Juncus effusus as Inhibitors of OAT1 and OAT3.
Sources gouvernementales
Aucune monographie gouvernementale directe n'est disponible pour cette plante. Le contenu ci-dessous est généré par IA et n'a pas été vérifié par rapport à une source gouvernementale faisant autorité. Utilisez les liens de recherche pour consulter les sources officielles avant de vous fier à ces informations.
6.PMID: 35976112 (2022) — Chromosome-scale genome assemblies and annotations for Poales species Carex cristatella, Carex scoparia, Juncus effusus, and Juncus inflexus. · G3 (Bethesda, Md.)
7.PMID: 35162880 (2022) — Physiological and Psychological Effects of Volatile Organic Compounds from Dried Common Rush (Juncus effusus L. var. decipiens Buchen.) on Humans. · International journal of environmental research and public health
8.PMID: 31195970 (2019) — RNA-Seq analysis of soft rush (Juncus effusus): transcriptome sequencing, de novo assembly, annotation, and polymorphism identification. · BMC genomics
9.PMID: 37312583 (2024) — Phytochemical, ethnomedicinal uses and pharmacological profile of Juncus decipiens (Buchenau) Nakai (common rush). · Natural product research
10.PMID: 38969456 (2024) — Construction of a BiOI/ZnO heterojunction on biomass Juncus effusus fiber for photodegradation of organic pollutants. · Journal of environmental sciences (China)
11.PMID: 35028318 (2022) — Anti-Inflammatory and Protective Effects of Juncus effusus L. Water Extract on Oral Keratinocytes. · BioMed research international
13.PMID: 40068564 (2025) — Beneficial effect of Juncus effusus extract powder enriched with dehydroeffusol on the cognitive and dexterous performance of elderly people: A randomized, double-blind, placebo-controlled, parallel-group study. · Nutrition (Burbank, Los Angeles County, Calif.)
14.PMID: 38461471 (2024) — How diverse a monocentric chromosome can be? Repeatome and centromeric organization of Juncus effusus (Juncaceae). · The Plant journal : for cell and molecular biology
16.PMID: 34027070 (2021) — Characterization and phylogenetic analysis of the complete chloroplast genome of Juncus effusus L. · Mitochondrial DNA. Part B, Resources
17.PMID: 22017742 (2012) — Phenanthrenes from Juncus effusus with anxiolytic and sedative activities. · Natural product research
19.PMID: 26072042 (2015) — Four new phenanthrenoid dimers from Juncus effusus L. with cytotoxic and anti-inflammatory activities. · Fitoterapia
20.PMID: 39615210 (2025) — Effusol ameliorates ischemic stroke by targeting NLRP3 protein to regulate NLRP3 inflammasome-mediated pyroptosis. · Phytomedicine : international journal of phytotherapy and phytopharmacology
21.PMID: 16289221 (2006) — Phytotreatment of propellant contamination. · Chemosphere
22.PMID: 28578950 (2017) — Characterization of a novel natural cellulosic fiber from Juncus effusus L. · Carbohydrate polymers
23.PMID: 32333241 (2020) — Dehydroeffusol Rescues Amyloid β25-35-Induced Spatial Working Memory Deficit. · Plant foods for human nutrition (Dordrecht, Netherlands)
24.PMID: 12126307 (2002) — Antimicrobial DNA-binding photosensitizers from the common rush, Juncus effusus. · Photochemistry and photobiology